In Brief: Guidant/Hewlett-Packard
This article was originally published in The Gray Sheet
Executive SummaryGuidant/Hewlett-Packard: Sign agreement to develop and market a new high-frequency intravascular ultrasound diagnostic catheter. Under the terms of the deal, HP will develop the IVUS imaging core. Guidant will act as the original equipment manufacturer of the catheter sheath and will market the finished product. The agreement expands on two previous deals between the firms -- an August 1996 agreement for use of HP's IVUS technology in Guidant's SureCut guided directional coronary atherectomy catheter ("The Gray Sheet" Sept. 2, 1996, I&W-4), and a November 1996 agreement for distribution of HP's coronary and peripheral IVUS catheters and consoles by Guidant...
You may also be interested in...
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.
The Swiss giant is hoping to get seven more approvals for its blockbuster immunology drug over the next 10 years.
Cadila has filed for approval of saroglitazar for NASH in India. The drug, which could emerge as the first medicine for the indication if approved, is already being used by a million Indian patients for diabetic dyslipidemia and hypertriglyceridemia.